Stryker (SYK) Financials

Stryker Corp (SYK) is a global medical technology company specializing in surgical equipment and medical devices. The company’s income statement shows a consistent growth in revenue over the years. In 2020, Stryker Corp reported a total revenue of $14.8 billion, an increase of 3.7% from the previous year. This growth can be attributed to the company’s strong product portfolio and its ability to innovate and bring new technologies to the market. Stryker Corp also recorded a gross profit of $9.5 billion in 2020, representing a gross margin of 64.2%. The company’s net income from stockholders was $2.5 billion, reflecting a net margin of 17.1%. These figures demonstrate Stryker Corp’s ability to generate profits and create value for its shareholders.

Looking at Stryker Corp’s balance sheet, we can see that the company has a strong financial position. The company’s total assets amount to $36.9 billion, while its total liabilities stand at $18.8 billion. This gives Stryker Corp a healthy stockholders’ equity of $18.1 billion. The company also has a low level of debt, with a total debt of $1.3 billion. Stryker Corp’s cash equivalents, which include cash and short-term investments that can be readily converted into cash, amount to $5.7 billion. This indicates the company’s ability to meet its short-term obligations and invest in growth opportunities. In terms of cash flow, Stryker Corp has a positive operating cash flow of $2.7 billion, which shows its ability to generate cash from its core operations. The company also has a positive investing cash flow of $2.5 billion, indicating its investments in new technologies and acquisitions. Stryker Corp’s free cash flow, which is the cash left over after deducting capital expenditures, is $1.9 billion. This suggests the company has the financial flexibility to pursue growth initiatives and return value to its shareholders. Lastly, Stryker Corp’s financing cash flow is -$1.9 billion, mainly due to its repayment of long-term debt and payment of dividends to shareholders.